NCT04785053 - Memory Functions in Mild Alzheimer's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 22, 2020

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions

Alzheimer Disease

Interventions

DEVICE

transcranial alternating current stimulation (tACS)

The tACS intervention (gamma stimulation, theta stimulation and active sham condition) will be administered to the participants over three visits that will be completed within one of the working days (Mon-Fri) at approximately the same time of day for all participants. Participants will be randomized and blinded to the tACS treatment.

Trial Locations (1)

02131

Hinda and Arthur Marcus Institute for Aging Research, Boston

All Listed Sponsors

lead

Hebrew SeniorLife

OTHER